C. H. Chilton

994 total citations
42 papers, 804 citations indexed

About

C. H. Chilton is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, C. H. Chilton has authored 42 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 22 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in C. H. Chilton's work include Clostridium difficile and Clostridium perfringens research (40 papers), Microscopic Colitis (22 papers) and Gut microbiota and health (11 papers). C. H. Chilton is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (40 papers), Microscopic Colitis (22 papers) and Gut microbiota and health (11 papers). C. H. Chilton collaborates with scholars based in United Kingdom, United States and Italy. C. H. Chilton's co-authors include Jane Freeman, G. S. Crowther, Mark H. Wilcox, S. L. Todhunter, Simon D. Baines, M. H. Wilcox, Scott Nicholson, Anthony M. Buckley, Christopher Longshaw and Claudia Vuotto and has published in prestigious journals such as Gastroenterology, PLoS ONE and Nature Reviews Microbiology.

In The Last Decade

C. H. Chilton

41 papers receiving 795 citations

Peers

Countries citing papers authored by C. H. Chilton

Since Specialization

Citations

This map shows the geographic impact of C. H. Chilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. H. Chilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. H. Chilton more than expected).

Fields of papers citing papers by C. H. Chilton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. H. Chilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. H. Chilton. The network helps show where C. H. Chilton may publish in the future.

Co-authorship network of co-authors of C. H. Chilton

This figure shows the co-authorship network connecting the top 25 collaborators of C. H. Chilton. A scholar is included among the top collaborators of C. H. Chilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. H. Chilton. C. H. Chilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trial 2025 ·British journal of surgery ·Jack Helliwell, C. H. Chilton, Caroline Young, Emma Clark, (unknown), (unknown), (unknown), Julie Croft, Neil Corrigan, Andrew Kirby, Philip Quirke, Deborah Stocken, David Jayne, Henry M. Wood	0
2	Clostridioides difficile pathogenesis and control 2025 ·Nature Reviews Microbiology ·C. H. Chilton, Virginie Viprey, (unknown), Inês B. Moura, Anthony M. Buckley, Jane Freeman, (unknown), Mark H. Wilcox	1
3	The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model 2021 ·Journal of Hospital Infection ·Hannah C. Harris, Anthony M. Buckley, (unknown), (unknown), Emma Clark, (unknown), Karen L. de Mesy Bentley, Inês B. Moura, Mark H. Wilcox, Neil Woodford, Kerrie Davies, C. H. Chilton	8
4	Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon 2020 ·BMC Microbiology ·Inês B. Moura, (unknown), (unknown), Emma Clark, Mark H. Wilcox, Anthony M. Buckley, C. H. Chilton	5
5	Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon 2019 ·Journal of Antimicrobial Chemotherapy ·Christopher Rooney, Anna E. Sheppard, Emma Clark, Kerrie Davies, Alasdair T. M. Hubbard, Robert Sebra, Derrick W. Crook, A. Sarah Walker, Mark H. Wilcox, C. H. Chilton	22
6	Investigating the effect of supplementation on Clostridioides (Clostridium) difficile spore recovery in two solid agars 2018 ·Anaerobe ·(unknown), Jon J. Vernon, Jane Freeman, Mark H. Wilcox, C. H. Chilton	4
7	Biofilm-derived spores of Clostridioides (Clostridium) difficile exhibit increased thermotolerance compared to planktonic spores 2018 ·Anaerobe ·(unknown), Mark H. Wilcox, C. H. Chilton	5
8	Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production 2016 ·PLoS ONE ·C. H. Chilton, G. S. Crowther, Helen Ashwin, Christopher Longshaw, Mark H. Wilcox	27
9	Potential of lactoferrin to prevent antibiotic-inducedClostridium difficileinfection 2016 ·Journal of Antimicrobial Chemotherapy ·C. H. Chilton, G. S. Crowther, Klaudyna Śpiewak, Małgorzata Brindell, G. Singh, Mark H. Wilcox, Tanya Monaghan	24
10	An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile Infection 2016 ·Methods in molecular biology ·G. S. Crowther, Mark H. Wilcox, C. H. Chilton	13
11	Efficacy of vancomycin extended-dosing regimens for treatment of simulatedClostridium difficileinfection within anin vitrohuman gut model 2016 ·Journal of Antimicrobial Chemotherapy ·G. S. Crowther, C. H. Chilton, Christopher Longshaw, S. L. Todhunter, (unknown), Jon J. Vernon, Andreas Karas, Mark H. Wilcox	13
12	Predictive Values of Models of Clostridium difficile Infection 2015 ·Infectious Disease Clinics of North America ·C. H. Chilton, Jane Freeman	4
13	Efficacy of alternative fidaxomicin dosing regimens for treatment of simulatedClostridium difficileinfection in anin vitrohuman gut model 2015 ·Journal of Antimicrobial Chemotherapy ·C. H. Chilton, G. S. Crowther, S. L. Todhunter, Helen Ashwin, Christopher Longshaw, Alexei Karas, Mark H. Wilcox	23
14	Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model 2014 ·Journal of Antimicrobial Chemotherapy ·G. S. Crowther, C. H. Chilton, S. L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines, M. H. Wilcox	35
15	Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota 2014 ·PLoS ONE ·G. S. Crowther, C. H. Chilton, S. L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines, Mark H. Wilcox	39
16	Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery 2013 ·Journal of Antimicrobial Chemotherapy ·C. H. Chilton, Jane Freeman, Simon D. Baines, G. S. Crowther, Scott Nicholson, Mark H. Wilcox	21
17	Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure 2013 ·Journal of Antimicrobial Chemotherapy ·C. H. Chilton, G. S. Crowther, Jane Freeman, S. L. Todhunter, Scott Nicholson, Christopher Longshaw, Mark H. Wilcox	41
18	Mixed infection by Clostridium difficile in an in vitro model of the human gut 2013 ·Journal of Antimicrobial Chemotherapy ·Simon D. Baines, G. S. Crowther, S. L. Todhunter, Jane Freeman, C. H. Chilton, Warren N. Fawley, Mark H. Wilcox	12
19	Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model 2012 ·Journal of Antimicrobial Chemotherapy ·C. H. Chilton, Jane Freeman, G. S. Crowther, S. L. Todhunter, Mark H. Wilcox	25
20	Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model 2012 ·Journal of Antimicrobial Chemotherapy ·Jane Freeman, Miriam Marquis, G. S. Crowther, S. L. Todhunter, Warren N. Fawley, C. H. Chilton, Greg Moeck, Dario Lehoux, Mark H. Wilcox	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact